To explore the potential role of DNA methylation on HLA-G expression in ovarian cancer, we tested the effect of the methylation inhibitor 5-aza-deoxycytidine on methylation within the CpG-enriched regulatory region of the HLA-G gene and correlated changes in expression in an ovarian cancer cell line. Here, HLA-G is linked to ovarian carcinoma.